VENTXP1 and head and neck squamous cell carcinoma: In summary, our study identifies that VENTXP1 competitively sponges miR-205-5p to block the suppressive effect of miR-205-5p on ANKRD2, regulating NF-kB signaling and then inhibiting HNSCC proliferation (Fig. 7).